Shoji Sera, Ayumu Furuya, Yoshiki Kameda, Akira Okada, Naomi Nagai. Rationale for Contraindications for Pregnant and Breast-Feeding Women in the Package Inserts of Prescription Drugs and Changes in Information by the Revised Instructions. Jpn.J.Soc.Pharm. 2024. 43. 1. 31-39
Kimihiko Tanizawa, Yuki Nishimura, Shoji Sera, Daichi Yaguchi, Akira Okada, Masakatsu Nishikawa, Satoshi Tamaru, Naomi Nagai. Incidence of stroke, systemic embolism and bleeding events in patients without anticoagulation based on real-world data in Japan: a retrospective cohort study. BMJ Open. 2022. 12. 11. e063623-e063623
Shiori Fukumoto, Masayuki Ohbayashi, Akira Okada, Noriko Kohyama, Tatsuro Tamatsukuri, Hideki Inoue, Akihito Kato, Toru Kotani, Hironori Sagara, Kenji Dohi, et al. Population Pharmacokinetic Model and Dosing Simulation of Meropenem Using Measured Creatinine Clearance for Patients with Sepsis. Ther Drug Monit. 2022. 45. 3. 392-399
Akimitsu Maeda, Hitoshi Ando, Kei Irie, Naoya Hashimoto, Jun-Ichi Morishige, Shoji Fukushima, Akira Okada, Hiromichi Ebi, Masahide Matsuzaki, Hiroji Iwata, et al. Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib. Eur J Clin Pharmacol. 2022. 78. 8. 1239-1247
Akira Okada, Shoji Sera, Maho Taguchi, Hiroaki Yamada, Naomi Nagai. Analysis of drug adverse events in elderly patients based on the Japanese Adverse Drug Event Report Database. J Clin Pharm Ther. 2022. 47. 8. 1264-1269
国際TDM学会
, JAPANESE SOCIETY OF PHARMACEUTICAL HEALTH CARE AND SCIENCES
, 日本TDM学会
, THE JAPANESE SOCIETY FOR THE STUDY OF XENOBIOTICS
, THE PHARMACEUTICAL SOCIETY OF JAPAN
, 日本医薬品情報学会
, レギュラトリーサイエンス学会
, 日本臨床薬理学会